YS BIOPHARMA CO LTD (LSB)
Institutional ownership reported to the SEC as of Q3 2024, across 7 quarters.
7
Reporting holders
$2.2M
Reported value
0.0%
Held as options
-4
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| FMR LLC | $802.7K | 1,165,071 | 0.00% | 7q | HELD |
| HHLR ADVISORS, LTD. | $512.7K | 751,790 | 0.01% | 7q | HELD |
| FIL Ltd | $424.1K | 615,475 | 0.00% | 7q | -16.1%-$81.3K |
| SUPERSTRING CAPITAL MANAGEMENT LP | $212.2K | 307,920 | 0.19% | 4q | HELD |
| BARCLAYS PLC | $168.8K | 247,575 | 0.00% | 2q | HELD |
| BANK OF MONTREAL /CAN/ | $75.5K | 93,808 | 0.00% | 3q | -68.0%-$160.1K |
| UBS Group AG | $33.7K | 49,418 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 7 | $2.2M | 3,231,057 | 1 | 0 | 2 | 0.0% |
| Q2 2024 | 11 | $3.3M | 5,118,717 | 4 | 0 | 3 | 0.0% |
| Q1 2024 | 9 | $3.8M | 5,372,201 | 1 | 0 | 2 | 0.0% |
| Q4 2023 | 10 | $4.9M | 9,327,561 | 1 | 0 | 3 | 0.0% |
| Q3 2023 | 11 | $8.9M | 11,160,657 | 2 | 1 | 1 | 0.0% |
| Q2 2023 | 14 | $15.4M | 11,127,838 | 5 | 1 | 2 | 0.0% |
| Q1 2023 | 12 | $22.2M | 13,905,280 | 11 | 0 | 0 | 0.0% |